Related Experiment Videos
Survival of nodular versus diffuse pattern lymphocytic poorly differentiated lymphoma
Cancer
|May 1, 1978
Summary
Nodular Lymphocytic Poorly Differentiated Lymphoma (NLPD) patients showed superior response and survival rates compared to Diffuse Lymphocytic Poorly Differentiated (DLPD) patients. Aggressive chemotherapy is recommended for DLPD, while NLPD may benefit from less intensive treatments.
Area of Science:
- Hematology
- Oncology
- Clinical Medicine
Background:
- Nodular Lymphocytic Poorly Differentiated Lymphoma (NLPD) and Diffuse Lymphocytic Poorly Differentiated (DLPD) are distinct lymphoma subtypes.
- Treatment strategies for these lymphomas often involve varying chemotherapy intensities.
Purpose of the Study:
- To compare treatment response and survival rates between NLPD and DLPD patients.
- To evaluate the impact of chemotherapy intensity on outcomes for both lymphoma types.
Main Methods:
- Retrospective analysis of 97 NLPD and 77 DLPD patients.
- Comparison of outcomes between intensive and moderate chemotherapy regimens.
- Assessment of response rates (complete and overall) and two-year survival.
Main Results:
- NLPD demonstrated significantly higher complete (47%) and overall (81%) response rates compared to DLPD (25% and 59%).
- Two-year survival was significantly better for NLPD (83%) than DLPD (47%).
- Chemotherapy response strongly influenced DLPD survival, but less so for NLPD.
Conclusions:
- Aggressive multi-agent chemotherapy is justified for DLPD, with complete response being crucial for survival.
- NLPD exhibits favorable survival rates, potentially allowing for trials with moderate-intensity or single-agent chemotherapy.